NASDAQ · Medical - Instruments & Supplies

NNNN (NNNN) Stock

$11.13 +9.66% NASDAQ: NNNN Healthcare

Valuation

MetricValue
Price$11.13
Market Cap$488.51M
P/E Ratio172.00
P/B Ratio37.55
P/S Ratio116.20
EPS (TTM)$0.15
52-Week High$55.65
52-Week Low$9.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE27.05%
ROA14.66%
ROCE20.00%
Gross Margin87.06%
Operating Margin66.47%
Net Margin73.75%
Debt/Equity0.00
Current Ratio344.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.0M$24.0M$7.0M$8.0M$9.0M
Operating Profit$2.0M$10.0M$2.0M$2.0M$6.0M
Net Profit$3.0M$10.0M$2.0M$2.0M$6.0M
EPS$0.03$0.07$0.01$0.06$0.16
Op Margin55.5%43.3%29.2%24.4%66.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$5.0M$14.0M$16.0M$19.0M$30.0M
Total Liabilities$2.0M$1.0M$1.0M$2.0M$0
Cash$4.0M$7.0M$10.0M$12.0M$8.0M
Borrowings$0$0$0$0$0

Latest News

Anbio Biotechnology Files Mixed Shelf Registration MT Newswires · Jul 9, 2026 US Undiscovered Gems To Watch In May 2026 Simply Wall St. · May 29, 2026 Discover 3 Undiscovered Gems in the US Market Simply Wall St. · May 29, 2026 Uncovering US Market's 3 Undiscovered Gems With Potential Simply Wall St. · May 28, 2026 Discovering US Undiscovered Gems In May 2026 Simply Wall St. · May 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$4.0M$4.0M$1.0M$2.0M$-7.0M
Investing Cash Flow$0$-2.0M$2.0M$0$-4.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$4.0M$3.0M$3.0M$2.0M$-4.0M
Free Cash Flow$4.0M$4.0M$1.0M$2.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.91
EV / EBITDA187.40
FCF Yield0.14%
Quick Ratio344.31
Interest Coverage—
Return 1Y-77.97%
Return 3Y—
Return 5Y—

Ownership

Insiders Held4.78%
Institutions Held4.90%
Institutions Float Held5.15%
Institutional HolderSharesReport Date
Geode Capital Management, LLC25,7632026-03-31
BNP Paribas Financial Markets10,4002026-03-31
Morgan Stanley7,3382026-03-31
UBS Group AG6,3392026-03-31
Blue Trust, Inc.52026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANGO $14.63 +2.02% -14.36 $604.69M 0.00%
AVNS $24.99 +0.04% 19.96 $1.17B 0.00%
CLPT $14.14 -2.68% -13.09 $424.05M 0.00%
CMPSCOMPASS Pathways plc $13.31 -0.60% -6.19 $1.28B 0.00%
CYHCommunity Health Systems, Inc. $2.70 -1.10% -1.21 $380.48M 0.00%

About NNNN

NNNN is led by CEO Michael Lau, employs 27 people, headquartered in DE, publicly traded since 2025.

NNNN stock trades at $11.13 with a market capitalization of $488.51M. The stock is valued at a price-to-earnings (P/E) ratio of 172.00, price-to-book of 37.55, price-to-sales of 116.20. Over the past 52 weeks the stock has ranged between $9.08 and $55.65, and currently trades 80.0% below its 52-week high.

On profitability, NNNN generates a return on equity (ROE) of 27.05% — well above the market average, a sign of a high-quality business, return on capital employed of 20.00%, an operating margin of 66.47%, a net profit margin of 73.75%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides